RBPWorld - a comprehensive database of RNA Binding Proteins

Welcome to

RBP World!

Drugs target to MAPT

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
TILAVONEMAB	Antibody	progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
BEPRANEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Active, not recruiting	ClinicalTrials
GOSURANEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Terminated	ClinicalTrials
POSDINEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
SEMORINEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
GOSURANEMAB	Antibody	Classical progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	1.0	Terminated	ClinicalTrials
TILAVONEMAB	Antibody	progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	2.0	Terminated	ClinicalTrials
BEPRANEMAB	Antibody	progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
ZAGOTENEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
TILAVONEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Terminated	ClinicalTrials
SEMORINEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Terminated	ClinicalTrials
TILAVONEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Completed	ClinicalTrials
GOSURANEMAB	Antibody	progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	1.0	Completed	ClinicalTrials
GOSURANEMAB	Antibody	Classical progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	2.0	Terminated	ClinicalTrials
ZAGOTENEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Completed	ClinicalTrials
BEPRANEMAB	Antibody	progressive supranuclear palsy	Microtubule-associated protein tau inhibitor	1.0	Active, not recruiting	ClinicalTrials
SEMORINEMAB	Antibody	Alzheimer disease	Microtubule-associated protein tau inhibitor	2.0	Active, not recruiting	ClinicalTrials